6月13日周五盘中，燃石医学（股票代码：BNR）股价出现大幅下跌，跌幅高达6.95%，引发市场关注。这家专注于癌症诊断的生物科技公司股价波动，反映出投资者对其经营状况的担忧。
根据最新财报数据，燃石医学实现营业收入1829万美元，但净亏损达186万美元，每股亏损0.17美元。这种亏损状态可能是导致投资者信心下降的主要原因之一。此外，该股当日成交量仅为2590股，换手率低至0.02%，表明市场对该股的交易兴趣不高。
值得注意的是，燃石医学所在的生命科学行业整体呈现下跌趋势，行业跌幅为0.62%。这种行业性下滑也可能对燃石医学的股价产生负面影响。目前，还没有机构对该股给出明确的投资建议，这种不确定性可能进一步加剧了投资者的观望情绪。作为一家专注于NGS基因测序技术的癌症诊断公司，燃石医学的未来发展仍然值得市场持续关注。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.